COMP <GO>
ADUS vs NEO // NET PROFIT MARGIN
Addus HomeCare Corporation (NASDAQ) VS. NeoGenomics Inc. (NASDAQ) • 15-METRIC TALLY: ADUS 8
— NEO 1
▲ NET PROFIT MARGIN LEADER: ADUS
LAST: $124.34 (+1.77%) • MKT CAP: $2.32B
net-margins
6.70%
LAST: $17.93 (-0.33%) • MKT CAP: $2.32B
net-margins
-14.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ADUS VS. NEO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ADUS | NEO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.50% | 43.20% | -10.70 | NEO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.10% | -9.00% | +18.10 | ADUS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.8x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.47% | -0.94% | +5.41 | ADUS | /fcf-yield <GO> |
| Operating Margin | 9.70% | -15.90% | +25.60 | ADUS | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 6.70% | -14.80% | +21.50 | ADUS | /net-margins <GO> |
| Revenue Growth (YoY) | 23.20% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.83 | 2.72 | +3.11 | ADUS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 5/9 | +4.00 | ADUS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 73.1 | 51.0 | +22.14 | ADUS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.3x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.32B | $2.32B | $2.0M | ADUS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ADUS REV | NEO REV | ADUS GROSS % | NEO GROSS % | ADUS FCF | NEO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.42B | $727.3M | 32.5% | 43.2% | $103.8M | -$21.8M |
| FY 2024 | $1.15B | $660.6M | 32.5% | 43.9% | $110.4M | -$34.0M |
| FY 2023 | $1.06B | $0 | — | — | $112.2M | -$2.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ADUS // BETA —
NEO // BETA —